Published in AIDS on November 01, 1993
HIV seroprevalence rates in Benin. AIDS (1994) 0.81
Worldwide epidemiology of human adenovirus infections. Am J Epidemiol (1983) 3.45
Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol (1999) 2.96
Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest (1999) 2.78
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch (1972) 2.47
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol (2000) 2.21
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence. Arch Gesamte Virusforsch (1972) 2.04
Tomographic 3D reconstruction of quick-frozen, Ca2+-activated contracting insect flight muscle. Cell (1999) 1.85
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70
Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol (1990) 1.61
Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci (2000) 1.60
Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis (1991) 1.49
Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis (2001) 1.40
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
X-ray diffraction indicates that active cross-bridges bind to actin target zones in insect flight muscle. Biophys J (1998) 1.38
Microbial and chemical transformations of some 12,13-epoxytrichothec-9,10-enes. Appl Environ Microbiol (1978) 1.32
Arthroscopic treatment of septic joints: prognostic factors. Arch Orthop Trauma Surg (2002) 1.32
Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32
Improved detection of virus-specific IgM antibodies. Elimination of non-specific IgM binding. J Gen Virol (1978) 1.31
Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med (1975) 1.30
Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae. J Clin Invest (1988) 1.28
Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation (1982) 1.27
Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. J Virol (2001) 1.25
Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol (2000) 1.24
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Antibodies to human cytomegalovirus structural polypeptides during primary infection. J Virol Methods (1988) 1.23
Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut (1982) 1.22
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) (1986) 1.20
A haemorrhagic fever from the Côte d'Ivoire. Lancet (1999) 1.17
Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol (2001) 1.17
Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol (1991) 1.16
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood (1990) 1.15
Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS (1998) 1.14
Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen. J Clin Microbiol (1982) 1.13
Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol (1989) 1.12
Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 1.12
Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol (1994) 1.09
Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis (1993) 1.08
Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill (2005) 1.08
Acute Epstein-Barr virus infections in children. Med Microbiol Immunol (1972) 1.08
Antitumor activity of 15-acetoxyscirpen-3,4-diol. J Antibiot (Tokyo) (1978) 1.08
Simple detection of fluorescent stained IgM in sucrose gradients: demonstration of virus-specific IgM. Intervirology (1974) 1.04
Rift Valley fever in Nigeria: infections in domestic animals. Rev Sci Tech (1996) 1.04
The infrared receptor of Melanophila acuminata De Geer (Coleoptera: Buprestidae): ultrastructural study of a unique insect thermoreceptor and its possible descent from a hair mechanoreceptor. Tissue Cell (1995) 1.03
Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg (2007) 1.02
A novel model for the study of the therapy of flavivirus infections using the Modoc virus. Virology (2001) 1.02
Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Rapid communication. Arch Virol (1989) 1.01
An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous. Graefes Arch Clin Exp Ophthalmol (1993) 1.00
Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr (2003) 0.99
Mechanisms of epithelial barrier impairment in HIV infection. Ann N Y Acad Sci (2000) 0.99
Cytomegalovirus as a frequent cause of Guillain-Barré syndrome. J Med Virol (1977) 0.99
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. J Clin Invest (1995) 0.98
Rapid method to detect rubella immunoglobulin M and immunoglobulin A antibodies. J Clin Microbiol (1975) 0.98
Cytomegalovirus myocarditis. Am Heart J (1980) 0.98
ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol (2000) 0.98
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology (2001) 0.97
Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem (1990) 0.96
Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations. J Med Virol (1986) 0.96
Rift Valley fever in Nigeria: infections in humans. Rev Sci Tech (1996) 0.96
Human immune response to proteins of cytomegalovirus. Intervirology (1980) 0.96
Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study. Clin Drug Investig (2005) 0.95
Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin. Biochem Biophys Res Commun (1996) 0.94
Human Kupffer cells infected with HIV-1 in vivo. J Acquir Immune Defic Syndr (1993) 0.94
RELATIONS OF HISTOLOGICAL STRUCTURE AND CLINICAL GROUPING TO THE PROGNOSIS OF CARCINOMATA OF THE BREAST AND UTERINE CERVIX. Ann Surg (1929) 0.94
[The risk of malaria transmission by blood transfusion at Cotonou, Benin]. Sante (2001) 0.94
Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann N Y Acad Sci (2000) 0.93
Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne. Int J Cancer (1975) 0.93
Detection of specific immunoglobulin M antibody to different flaviviruses by use of enzyme-labeled antigens. J Clin Microbiol (1984) 0.93
Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells. Regul Pept (2001) 0.93
Structural modifications of anguidin and antitumor activities of its analogues. J Med Chem (1982) 0.92
[Geoclimatology and severity of snake bite envenomations in Benin]. Bull Soc Pathol Exot (2002) 0.92
Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus. Rev Elev Med Vet Pays Trop (1996) 0.92
[Mast cells in skin altered by psoriasis--before, during and after cignolin therapy]. Dermatol Wochenschr (1967) 0.92
Gamma delta T cells in the peripheral blood of individuals from an area of holoendemic Plasmodium falciparum transmission. Trans R Soc Trop Med Hyg (1994) 0.92
Prevalence and risk-factors for Helicobacter pylori infection in urban and rural Beninese populations. Clin Microbiol Infect (2005) 0.92
[Cimetidine in the treatment of duodenal ulcer (author's transl)]. Dtsch Med Wochenschr (1978) 0.91
First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. Virology (2001) 0.91
Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1). Eur J Immunol (1991) 0.90
Calibration results obtained with Liulin-4 type dosimeters. Adv Space Res (2002) 0.89
[Granulomatous peritonitis from ascariasis: apropos of 1 case in a Benin child]. Bull Soc Pathol Exot (2000) 0.89
[Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung (1993) 0.88
Antibodies to ATLV/HTLV-1 in Africa. Med Microbiol Immunol (1984) 0.88
Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa). AIDS Res Hum Retroviruses (1991) 0.88
Endocrine effects of Lycopus europaeus L. following oral application. Arzneimittelforschung (1994) 0.87
Detection of coronavirus-like particles in homosexual men with acquired immunodeficiency and related lymphadenopathy syndrome. Klin Wochenschr (1985) 0.87
[Metabolism of the rabbit heart in situ during asphyxia and in post-asphyxial recovery]. Pflugers Arch (1970) 0.87
IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Cytokine (1998) 0.86
Strong IgG isotypic antibody response in sowdah type onchocerciasis. J Infect Dis (1994) 0.86
Hedamycin, a new antitumor antibiotic. I. Production, isolation, and characterization. Antimicrob Agents Chemother (Bethesda) (1966) 0.86
[Cytomegalovirus infection in the adult]. Dtsch Med Wochenschr (1973) 0.86
Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP). Acta Biochim Pol (2001) 0.86
Afferent projections of infrared-sensitive sensilla in the beetle Melanophila acuminata (Coleoptera: Buprestidae). Cell Tissue Res (1999) 0.86
[Epidemiological data on snake bite cases reported in Benin from 1994 to 2000]. Bull Soc Pathol Exot (2002) 0.86
Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials. Acta Neurochir (Wien) (1996) 0.86
Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology (2000) 0.85